90 related articles for article (PubMed ID: 11176434)
1. Evaluation of antibody class in response to endoscopic subureteral collagen injection in patients with vesicoureteral reflux.
Inoue K; Nakamoto T; Usui A; Usui T
J Urol; 2001 Feb; 165(2):555-8. PubMed ID: 11176434
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic subureteral glutaraldehyde cross-linked collagen injection for the treatment of secondary vesicoureteral reflux: comparison with primary vesicoureteral reflux in adults.
Inoue K; Nakamoto T; Usui A; Usui T
J Urol; 2000 Aug; 164(2):336-9. PubMed ID: 10893579
[TBL] [Abstract][Full Text] [Related]
3. Pitfalls of repeat subureteral bovine collagen injections for the endoscopic treatment of vesicoureteral reflux.
Haferkamp A; Möhring K; Staehler G; Dörsam J
J Urol; 2000 Jun; 163(6):1919-21. PubMed ID: 10799229
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases.
Haferkamp A; Möhring K; Staehler G; Gerner HJ; Dörsam J
J Urol; 2000 Jan; 163(1):274-7. PubMed ID: 10604375
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic treatment of vesicoureteral reflux in children: our experience and analysis of factors affecting success rate.
Alkan M; Ciftci AO; Senocak ME; Tanyel FC; Buyukpamukcu N
Urol Int; 2008; 81(1):41-6. PubMed ID: 18645270
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic subureteral collagen injection: are immunological concerns justified?
Leonard MP; Decter A; Hills K; Mix LW
J Urol; 1998 Sep; 160(3 Pt 2):1012-6. PubMed ID: 9719266
[TBL] [Abstract][Full Text] [Related]
7. GAX 65: new injectable cross-linked collagen for the endoscopic treatment of vesicoureteral reflux--a double-blind study evaluating its efficiency in children.
Frey P; Gudinchet F; Jenny P
J Urol; 1997 Sep; 158(3 Pt 2):1210-2. PubMed ID: 9258175
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic subureteral collagen injection for the treatment of vesicoureteral reflux in infants and children.
Frey P; Lutz N; Jenny P; Herzog B
J Urol; 1995 Aug; 154(2 Pt 2):804-7. PubMed ID: 7609184
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene.
Chertin B; De Caluwé D; Puri P
J Urol; 2003 May; 169(5):1847-9; discussion 1849. PubMed ID: 12686860
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic treatment of vesicoureteral reflux in patients with myelodysplasia.
Yokoyama O; Ishiura Y; Seto C; Uchibayashi T; Ohkawa M
J Urol; 1996 Jun; 155(6):1882-6. PubMed ID: 8618279
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic subureteral urocol injection for the treatment of vesicoureteral reflux.
Kajbafzadeh AM; Habibi Z; Tajik P
J Urol; 2006 Apr; 175(4):1480-3; discussion 1483-4. PubMed ID: 16516028
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic treatment of vesicoureteral reflux with polydimethylsiloxane in adults: do location and appearance of the ureteric orifice have a role in the success rates?
Basok EK; Yildirim A; Atsu N; Gocer S; Tokuc R
Urol Int; 2008; 80(3):279-82. PubMed ID: 18480631
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of endoscopic subureteral polydimethylsiloxane injection for treatment of vesicoureteral reflux in children: a North American clinical report.
Herz D; Hafez A; Bagli D; Capolicchio G; McLorie G; Khoury A
J Urol; 2001 Nov; 166(5):1880-6. PubMed ID: 11586254
[TBL] [Abstract][Full Text] [Related]
14. Mound calcification after endoscopic treatment of vesicoureteral reflux with autologous chondrocytes--a normal variant of mound appearance?
Gargollo PC; Paltiel HJ; Rosoklija I; Diamond DA
J Urol; 2009 Jun; 181(6):2702-7; discussion 2707-8. PubMed ID: 19375743
[TBL] [Abstract][Full Text] [Related]
15. Durability of a single successful endoscopic polytetrafluoroethylene injection for primary vesicoureteral reflux: 14-year followup results.
Yücel S; Tarcan T; Simşek F
J Urol; 2007 Jul; 178(1):265-8; discussion 268. PubMed ID: 17499781
[TBL] [Abstract][Full Text] [Related]
16. Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up.
Haferkamp A; Contractor H; Möhring K; Staehler G; Dörsam J
Urology; 2000 May; 55(5):759-63. PubMed ID: 10792096
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antibody class in response to bovine collagen treatment in patients with urinary incontinence.
McClelland M; Delustro F
J Urol; 1996 Jun; 155(6):2068-73. PubMed ID: 8618338
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic calcification of subureteral collagen ten years after injection.
Nepple KG; Knudson MJ; Cooper CS; Austin JC
Urology; 2007 May; 69(5):982.e1-2. PubMed ID: 17482948
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic treatment of vesicoureteral reflux with polydimethylsiloxane in adult women.
Choo MS; Hong B; Ji YH; Chung H; Choe JH; Park WH; Park T; Lee KS
Eur Urol; 2004 Jun; 45(6):787-9. PubMed ID: 15149753
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the behavior of some immunologic parameters after local, endoscopic autohemotherapy in children treated for vesicoureteral reflux].
Paradysz A; Hyla-Klekot L; Wielicki Z
Wiad Lek; 1998; 51 Suppl 3():114-9. PubMed ID: 9814119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
